Breaking news

AUB Group (ASX:AUB) Shares Drop On The Day, But Huge Gains On The Year

Investors in AUB Group Shares (ASX:AUB), a prominent player in the insurance broking and underwriting sector in Australia and New Zealand, are basking in the success of a 7.81% increase year to date. This figure highlights the substantial gains shareholders have enjoyed, far exceeding the pain of a total loss one might fear in stock…

Is it Too Late to Buy Sigma Healthcare

Proteomics International’s (ASX:PIQ) Delays the Launch of Kidney Disease Test in US

Proteomics International Laboratories (ASX:PIQ), a pioneer in the field of biomarker discovery and application, has suffered a stock price plummet following the announcement of a delay in the US market launch of its ground-breaking kidney disease predictive test. News of the setback saw the company’s shares tumble nearly 23%, wiping out recent gains as investors…

Car Group (ASX: CAR) – Should Investors Take Profits, Hold, or Buy?

Car Group (ASX: CAR) – Should Investors Take Profits, Hold, or Buy?

On 11 February Car Group (formerly Carsales.com) reported solid Half Year 2024 financial results. The stock price fell slightly on the release, only to rally, reaching an all-time high on 29 February. The stock price is up 873% since its 2009 listing on the ASX. Car Group was a fintech (financial technology) disruptor before the…

ASX This Week (W/C 18th March) – Earnings Thin On The Ground

As we get ready for a new week in the Aussie stock market, a little reflection on the last week is at least earned. With the ASX200 having seen a 2.25% drop and the XAO (All Ords) down 0.63%, we may be feeling a little bruised but it is always worth taking a longer view…

Can the Atlas Pearls (ASX: ATP) Share Price Regain Its Momentum?

Can the Atlas Pearls (ASX: ATP) Share Price Regain Its Momentum?

Atlas Pearls farms South Sea pearls, producing high-end jewelry. The company sells finished jewelry online and raw pearls to trade customers at auction. Following the release of outstanding Half Year 2024 results the surging share price fell. Atlas Pearls breaks conventional investing wisdom to stay clear of “one-trick-ponies.”  The company has a sole source of…

Apple (NASDAQ:AAPL) Poised to Propel Forward in AI – Shares Up More Than 1% In US AM

In an industry shift that signals Apple Inc.’s (NASDAQ:AAPL) intensified focus on artificial intelligence, the tech behemoth is on the brink of acquiring Brighter AI, a privately held startup that specialises in anonymizing private data within images. This tactical move aligns with Apple’s broader strategy to embed cutting-edge AI technology into its suite of products,…

Copper Stocks Shine While ASX 200 Dips Amid Macquarie’s Bank Downgrades

In today’s financial exchange, the ASX 200 index witnessed a minor decline, closing 15.8 points lower, representing a 0.20% dip in its overall value. Despite this modest drop, specific sectors and commodities contributed to a dynamic day in the markets. The limelight was undoubtedly taken by copper stocks, which experienced a prosperous ride due to…

Deep Yellow on the Top Ten Short List

Can Deep Yellow (ASX: DYL) Beat the Short Sellers?

Uranium explorer Deep Yellow has found its shares among the most shorted on the ASX. The company’s flagship asset is the Tumas Project in Namibia, Africa. Deep Yellow completed a $220 million dollar capital raise to continue funding exploration and development at Tumas. The rush of countries adopting ambitious carbon emission reduction targets coupled with…

Neurotech International (ASX:NTI) Extends NTI164 Rett Syndrome Clinical Trial to a Year

The biopharmaceutical development company Neurotech International (ASX:NTI) is extending the beacon of hope for those affected by Rett Syndrome with a significant expansion of its Phase I/II clinical trial. The investigation into the NTI164 drug formulation, derived from a specialized cannabis strain, will now continue for 52 weeks, marking an ambitious step in the hunt…

Insurance Australia Group’s Vigorous Stock Performance Amidst Modest Fundamentals

Investors in Insurance Australia Group Limited (ASX: IAG) have witnessed an encouraging stock performance with shares climbing 8.9% over the past three months. Amid this upward trend, analytical minds are considering whether IAG’s stock movements are rooted in solid financial fundamentals or if they stem from other market forces. For stakeholders, return on equity (ROE)…